{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T05:15:11Z","timestamp":1790054111613,"version":"4.0.1"},"reference-count":16,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:00:00Z","timestamp":1702684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00198-023-06998-y","type":"journal-article","created":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T01:01:46Z","timestamp":1702688506000},"page":"733-736","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5469-0153","authenticated-orcid":false,"given":"Naoya","family":"Fujita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motohiro","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akinori","family":"Sekizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Obuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,16]]},"reference":[{"key":"6998_CR1","unstructured":"Hildebrand GK, Kasi A (2022) Denosumab, in: StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL). https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535388\/. Accessed on May 31, 2023"},{"key":"6998_CR2","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","volume":"5","author":"HG Bone","year":"2017","unstructured":"Bone HG, Wagman RB, Brandi ML et al (2017) 10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension. Lancet Diabetes Endocrinol 5:513\u2013523. https:\/\/doi.org\/10.1016\/S2213-8587(17)30138-9","journal-title":"Lancet Diabetes Endocrinol"},{"key":"6998_CR3","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1177\/1078155218820927","volume":"25","author":"SM Nasser","year":"2019","unstructured":"Nasser SM, Sahal A, Hamad A, Elazzazy S (2019) Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: a retrospective cohort study. J Oncol Pharm Pract 25:1846\u20131852. https:\/\/doi.org\/10.1177\/1078155218820927","journal-title":"J Oncol Pharm Pract"},{"key":"6998_CR4","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1111\/1744-9987.12788","volume":"23","author":"A Torres-Ortiz","year":"2019","unstructured":"Torres-Ortiz A, Acharya P, Cheungpasitporn W (2019) Successful treatment of tuberculosis-associated hypercalcemia with denosumab in a patient with acute kidney injury. Ther Apher Dial 23:484\u2013485. https:\/\/doi.org\/10.1111\/1744-9987.12788","journal-title":"Ther Apher Dial"},{"key":"6998_CR5","doi-asserted-by":"publisher","first-page":"5544848","DOI":"10.1155\/2021\/5544848","volume":"2021","author":"AA Abd Jalil","year":"2021","unstructured":"Abd Jalil AA, Wan Muhamad Hatta SF, Mohamad AF, Abdul Rani MF (2021) Denosumab as the treatment of recalcitrant tuberculous pleural effusion-associated hypercalcemia. Case Rep Med 2021:5544848. https:\/\/doi.org\/10.1155\/2021\/5544848","journal-title":"Case Rep Med"},{"issue":"keaa109","key":"6998_CR6","doi-asserted-by":"publisher","first-page":"003","DOI":"10.1093\/rheumatology\/keaa109.003","volume":"59","author":"R Alshakh","year":"2020","unstructured":"Alshakh R, Gendi N (2020) EP04 Hypercalcemia of sarcoidosis in a patient with severe renal impairment successfully treated with denosumab. Rheumatology 59(keaa109):003. https:\/\/doi.org\/10.1093\/rheumatology\/keaa109.003","journal-title":"Rheumatology"},{"key":"6998_CR7","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1126\/science.175.4023.768","volume":"175","author":"LG Raisz","year":"1972","unstructured":"Raisz LG, Trummel CL, Holick MF, DeLuca HF (1972) 1,25-Dihydroxycholecalciferol: a potent stimulator of bone resorption in tissue culture. Science 175:768\u2013769. https:\/\/doi.org\/10.1126\/science.175.4023.768","journal-title":"Science"},{"key":"6998_CR8","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1126\/science.195343","volume":"197","author":"GL Wong","year":"1977","unstructured":"Wong GL, Luben RA, Cohn DV (1977) 1,25-Dihydroxycholecalciferol and parathormone: effects on isolated osteoclast-like and osteoblast-like cells. Science 197:663\u2013665. https:\/\/doi.org\/10.1126\/science.195343","journal-title":"Science"},{"key":"6998_CR9","doi-asserted-by":"publisher","first-page":"bqaa178","DOI":"10.1210\/endocr\/bqaa178","volume":"161","author":"T Mori","year":"2020","unstructured":"Mori T, Horibe K, Koide M et al (2020) The vitamin D receptor in osteoblast-lineage cells is essential for the proresorptive activity of 1\u03b1,25(OH)2D3 in vivo. Endocrinology 161:bqaa178. https:\/\/doi.org\/10.1210\/endocr\/bqaa178","journal-title":"Endocrinology"},{"key":"6998_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1172\/JCI14538","volume":"109","author":"RS Weinstein","year":"2002","unstructured":"Weinstein RS, Chen JR, Powers CC et al (2002) Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids. J Clin Invest 109:1041\u20131048. https:\/\/doi.org\/10.1172\/JCI14538","journal-title":"J Clin Invest"},{"key":"6998_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1210\/jcem-52-1-111","volume":"52","author":"TJ Hahn","year":"1981","unstructured":"Hahn TJ, Halstead LR, Baran DT (1981) Effects off short term glucocorticoid administration on intestinal calcium absorption and circulating vitamin D metabolite concentrations in man. J Clin Endocrinol Metab 52:111\u2013115. https:\/\/doi.org\/10.1210\/jcem-52-1-111","journal-title":"J Clin Endocrinol Metab"},{"key":"6998_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/0026-0495(83)90221-4","volume":"32","author":"Y Suzuki","year":"1983","unstructured":"Suzuki Y, Ichikawa Y, Saito E, Homma M (1983) Importance of increased urinary calcium excretion in the development of secondary hyperparathyroidism of patients under glucocorticoid therapy. Metabolism 32:151\u2013156. https:\/\/doi.org\/10.1016\/0026-0495(83)90221-4","journal-title":"Metabolism"},{"key":"6998_CR13","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/jcem.83.3.4621","volume":"83","author":"G Pearce","year":"1998","unstructured":"Pearce G, Tabensky DA, Delmas PD, Baker HW, Seeman E (1998) Corticosteroid-induced bone loss in men. J Clin Endocrinol Metab 83:801\u2013806. https:\/\/doi.org\/10.1210\/jcem.83.3.4621","journal-title":"J Clin Endocrinol Metab"},{"key":"6998_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s12020-018-1588-2","volume":"61","author":"J Compston","year":"2018","unstructured":"Compston J (2018) Glucocorticoid-induced osteoporosis: an update. Endocrine 61:7\u201316. https:\/\/doi.org\/10.1007\/s12020-018-1588-2","journal-title":"Endocrine"},{"key":"6998_CR15","doi-asserted-by":"publisher","first-page":"101148","DOI":"10.1016\/j.bonr.2021.101148","volume":"15","author":"K Horiuchi","year":"2021","unstructured":"Horiuchi K, Kobayashi E, Mizuno T, Susa M, Chiba K (2021) Hypercalcemia following discontinuation of denosumab therapy: a systematic review. Bone Rep 15:101148. https:\/\/doi.org\/10.1016\/j.bonr.2021.101148","journal-title":"Bone Rep"},{"key":"6998_CR16","first-page":"220","volume":"78","author":"WA Dik","year":"2020","unstructured":"Dik WA, Heron M (2020) Clinical significance of soluble interleukin-2 receptor measurement in immune-mediated diseases. Neth J Med 78:220\u2013231","journal-title":"Neth J Med"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00198-023-06998-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-023-06998-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:11:36Z","timestamp":1711015896000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00198-023-06998-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,16]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["6998"],"URL":"https:\/\/doi.org\/10.1007\/s00198-023-06998-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,16]]},"assertion":[{"value":"3 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from the patient to publish this case report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Naoya Fujita, Yosuke Ono, Kenichi Hashimoto, Yusuke Kawamura, Motohiro Kimata, Akinori Sekizawa, Yasuhiro Obuchi, and Yuji Tanaka declare that they have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}